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The lung is the interface between the environment
and the metabolic mechanisms of the body, and
plays a pivotal role in exposure to high altitude. In
fact, high altitude is a challenge for the human body
due to the progressive reduction of barometric pres-
sure and subsequent reduction of oxygen pressure,
leading to a series of important physiologic respons-
es that enable individuals to tolerate hypoxia and
secure the oxygen supply to tissues. These compen-
satory responses are known as the acclimatization
process. Most of the adaptations are observed from
2000 m a.s.l. and they become progressively more
evident with increasing altitude, from near sea level
through to moderate and extreme altitude. 
A new classification of altitude levels based on the
effects on performance and well-being has been re-
cently proposed [1]: the decrease in partial pressure
of oxygen reduces maximal oxygen uptake and im-
pairs "aerobic" performance by reducing maximal
aerobic power. Submaximal exercise performance
is also impaired at altitude. When the acclimatiza-
tion is not adequate, hypoxia triggers maladaptive
responses that lead to various forms of high altitude
illness or acute mountain sickness (AMS), character-
ized by headache plus gastrointestinal symptoms
(anorexia, nausea) and sleep disturbances. AMS is
present in 10-30% of subjects at altitudes between
2500 and 3000 m a.s.l. and is usually due to a fast
ascent. It is well defined by the short phrase: “Too
fast, too high”. Less frequent, but much more seri-
ous, consequences are high-altitude cerebral ede-
ma (HACE), and high-altitude pulmonary edema
(HAPE).
The lung response to acute altitude exposure is
mainly hyperventilation which, together with ele-
vated heart rate, aims at achieving an adequate sup-
ply of oxygen to the tissues. At rest, ventilation in-
creases by firstly increasing the tidal volume, at
least up to 3500 m. Above this altitude, also the
breathing rate significantly increases. Besides the
compensatory response, other mechanisms affect
lung physiology during hypoxic exposure: the in-
crease of pulmonary artery pressure and endothelial
permeability which can explain the extravascular
lung fluid accumulation described in many papers
[2]. It must be underlined that the interstitial fluid
accumulation which affects a large part of climbers
at high altitude should be considered a para-physio -
logical mechanism and does not predict subsequent
pulmonary edema [3]. 
The role of the lung in the acute exposure to altitude
was first described by Angelo Mosso, physiologist at
the University of Torino, at the end of the 19th cent -
ury. He very well pointed out the changes in venti-
lation and the reduction of lung volumes consistent
with the extravascular fluid accumulation in the
pulmonary interstitium [4]. 
However, mountain climate is characterized not
only by the progressive reduction of barometric and
inspiratory oxygen pressure, but also by other
changes that can variably affect respiratory function
and bronchial hyperresponsiveness: progressive re-
duction of air density, humidity, temperature,
aeroallergens, and outdoor pollution. The lower
density of air reduces respiratory resistances and in-
creases inspiratory and expiratory flows; this fact
explains the improvement of some parameters of
the forced exhalation curve observed at altitude.
The reduced temperature and the reduced humidity
cause hyperventilation of dry and cold air, especial-
ly during exercise; this fact could induce an asthma
attack, especially in subjects suffering from exercise
induced bronchospasm. The reduction or even the
absence of some aeroallergens (i.e. dermato -
phagoides) and outdoor pollution reduces the air-
way inflammation. Mountain climate can therefore
variably affect the respiratory system.
An increasing number of people travel each year to
high altitude for leisure, sport and even work pur-
poses. Because of the critical role played by the res-
piratory system in the adaptive and maladaptive re-
sponses, patients with underlying lung disease may
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be at increased risk for complications in this envi-
ronment and warrant careful evaluation before a so-
journ to higher altitudes. Given the high prevalence
of chronic respiratory diseases such as asthma and
COPD in the general population, it is to be expect-
ed that many patients will ask their physicians
about the safety of travel to altitude. This fact high-
lights the importance for physicians to have a good
understanding of the high-altitude environment, the
compensatory mechanisms of the body and high al-
titude illness. Advice for respiratory patients must
be founded on an adequate knowledge of the alti-
tude environment and the underlying disease. Is the
patient at risk of an asthma attack? Can the patient
adequately increase the ventilation? Has the patient
a gas exchange defect impairing the oxygen supply
at altitude? The severity of the disease and the alti-
tude to which the patient will go are critical points,
but the first rule is that the disease must be in a sta-
ble state.
The physician, after a careful examination of the pa-
tient, must take into account the level of hypoxia
(i.e. the altitude), the duration of exposure to hypox-
ic conditions, and the exercise intensity [5,6].
Heinrich Matthys in his paper in this issue [7] de-
scribes all these points, and provides physicians
with valuable recommendations for management of
respiratory patients prior to and during a sojourn at
high altitude.
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